Literature DB >> 18671332

Successful treatment of cardiac sarcoidosis with infliximab.

Cheryl Barnabe, James McMeekin, Andrew Howarth, Liam Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18671332

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  12 in total

Review 1.  Pathophysiology and clinical management of cardiac sarcoidosis.

Authors:  Nabeel Hamzeh; David A Steckman; William H Sauer; Marc A Judson
Journal:  Nat Rev Cardiol       Date:  2015-02-24       Impact factor: 32.419

Review 2.  Rheumatologic manifestations of sarcoidosis.

Authors:  Nadera J Sweiss; Karen Patterson; Ray Sawaqed; Umair Jabbar; Peter Korsten; Kyle Hogarth; Robert Wollman; Joe G N Garcia; Timothy B Niewold; Robert P Baughman
Journal:  Semin Respir Crit Care Med       Date:  2010-07-27       Impact factor: 3.119

3.  Controversies in the Treatment of Cardiac Sarcoidosis.

Authors:  Ogugua Ndili Obi; Elyse E Lower; Robert P Baughman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

Review 4.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

5.  TNF-alpha inhibition for the treatment of cardiac sarcoidosis.

Authors:  Matthew C Baker; Khushboo Sheth; Ronald Witteles; Mark C Genovese; Stanford Shoor; Julia F Simard
Journal:  Semin Arthritis Rheum       Date:  2019-11-15       Impact factor: 5.532

Review 6.  Management of extrapulmonary sarcoidosis: challenges and solutions.

Authors:  Khalid Al-Kofahi; Peter Korsten; Christian Ascoli; Shanti Virupannavar; Mehdi Mirsaeidi; Ian Chang; Naim Qaqish; Lesley A Saketkoo; Robert P Baughman; Nadera J Sweiss
Journal:  Ther Clin Risk Manag       Date:  2016-11-07       Impact factor: 2.423

7.  Lymph Vessel Proliferation on Cardiac Biopsy May Help in the Diagnosis of Cardiac Sarcoidosis.

Authors:  Yukiko Oe; Hatsue Ishibashi-Ueda; Taka-Aki Matsuyama; Yen-Hong Kuo; Toshiyuki Nagai; Yoshihiko Ikeda; Keiko Ohta-Ogo; Teruo Noguchi; Toshihisa Anzai
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

Review 8.  Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

Authors:  Maria Giovanna Trivieri; Paolo Spagnolo; David Birnie; Peter Liu; Wonder Drake; Jason C Kovacic; Robert Baughman; Zahi A Fayad; Marc A Judson
Journal:  J Am Coll Cardiol       Date:  2020-10-20       Impact factor: 24.094

9.  Case Report: TNFα Antagonists Are an Effective Therapy in Cardiac Sarcoidosis.

Authors:  Julien Stievenart; Guillaume Le Guenno; Marc Ruivard; Virginie Rieu; Marc André; Vincent Grobost
Journal:  Front Cardiovasc Med       Date:  2021-06-11

Review 10.  Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.

Authors:  Daniel Sánchez-Cano; José Luis Callejas-Rubio; Ricardo Ruiz-Villaverde; Raquel Ríos-Fernández; Norberto Ortego-Centeno
Journal:  Mediators Inflamm       Date:  2013-08-01       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.